Patent Litigation Survey Life Sciences IP Review is delighted to announce the launch of our Patent Litigation Survey. Created in partnership with Gowling WLG, the survey looks at patent litigation trends in the biologics and biosimilars space, as well other next generation therapies.The survey is open to anyone involved or interested in the business of biologics or next generation therapies such as T-cell or gene therapies, either as a corporate counsel or external legal counsel. We'd welcome participants from every jurisdiction. We ask for participants' details purely for verification, we will not publish participants' information. For a full outline of our privacy policy and GDPR information click here. OK Question Title * 1. Please add your information below Name * Email * Company Job role OK Question Title * 2. Do you work in-house private practice other (please specify) OK Question Title * 3. Does your company develop biologics? Yes No OK Question Title * 4. Does your company develop biosimilars? Yes No OK Question Title * 5. Have you been involved in biosimilar litigation? Yes No OK NEXT
